Molecular Templates to Participate in September Virtual Investor Conferences

AUSTIN, Texas, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates” or “MTEM”), a clinical-stage biopharmaceutical company focused on the discovery and development of the company’s proprietary engineered toxin bodies (ETBs), which are differentiated, targeted, biologic therapeutics for cancer and other serious diseases, today announced that it will deliver presentations at the Cantor Fitzgerald Virtual Global Healthcare Conference and the Morgan Stanley 18th Annual Global Healthcare Conference. In addition, management will be available for virtual 1on1 meetings at the Citi 15th Annual BioPharma Virtual Conference and Oppenheimer Fall Healthcare Life Sciences & MedTech Summit.

Citi 15th Annual BioPharma Virtual Conference
Conference Dates:	September 8 - 11
Available for 1on1 meetings on September 9
Cantor Fitzgerald Virtual Global Healthcare Conference
Conference Dates:Presentation Date:Time:	September 15 - 17September 152.40pm ET
Morgan Stanley 18th Annual Global Healthcare Conference
Conference Dates:Presentation Date:Time:	September 14 – 18September 1711.45am ET
Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Conference Dates:	September 21 - 23
Available for 1on1 meetings

The Cantor Fitzgerald and Morgan Stanley presentations will be webcast live and may be accessed via a link on the Molecular Templates website in the Investors section under Events.  Additionally, replays of the webcasts will be available on the corporate website following the conferences. 

About Molecular Templates  Molecular Templates is a clinical-stage company focused on the discovery and development of targeted biologic therapeutics. Our proprietary drug platform technology, known as engineered toxin bodies, or ETBs, leverages the resident biology of a genetically engineered form of Shiga-like Toxin A subunit to create novel therapies with potent and differentiated mechanisms of action for cancer and other serious diseases.

Investor Contact:

Adam CutlerChief Financial Officer [email protected] 862-204-4006

Source: Molecular Templates, Inc.

Source: Molecular Templates, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Wix.com Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Wix.com Ltd. - WIX
• NeOnc's NEO100 Phase 2a Brain Cancer Study Beats Historical Benchmark by Nearly 2.5x
• Outlook Therapeutics Announces Pricing of $55.0 Million Public Offering of Common Stock and Warrants